Literature DB >> 17043117

Quinolone resistance in Helicobacter pylori isolates in Germany.

Erik Glocker1, Hans-Peter Stueger, Manfred Kist.   

Abstract

We show that quinolone resistance in Helicobacter pylori has reached an alarming level in Germany. Our data suggest that the use of quinolones requires prior antimicrobial susceptibility testing, especially for isolates from patients who have already undergone previous unsuccessful eradication treatments, and also underline the further need for surveillance studies to monitor antibiotic resistance in H. pylori.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17043117      PMCID： PMC1797685          DOI： 10.1128/AAC.00614-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  24 in total

Review 1.  Helicobacter pylori infection.

Authors:  Sebastian Suerbaum; Pierre Michetti
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

2.  Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro.

Authors:  J E Bina; R A Alm; M Uria-Nickelsen; S R Thomas; T J Trust; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999).

Authors:  J Cabrita; M Oleastro; R Matos; A Manhente; J Cabral; R Barros; A I Lopes; P Ramalho; B C Neves; A S Guerreiro
Journal:  J Antimicrob Chemother       Date:  2000-12       Impact factor: 5.790

4.  European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori.

Authors:  Y Glupczynski; F Mégraud; M Lopez-Brea; L P Andersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-11       Impact factor: 3.267

5.  Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori.

Authors:  G Wang; T J Wilson; Q Jiang; D E Taylor
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 6.  Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.

Authors:  P Malfertheiner; F Mégraud; C O'Morain; A P S Hungin; R Jones; A Axon; D Y Graham; G Tytgat
Journal:  Aliment Pharmacol Ther       Date:  2002-02       Impact factor: 8.171

7.  [Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid].

Authors:  C Toro; J García-Samaniego; J Carbó; A Iñiguez; T Alarcón; M López-Brea; M Baquero
Journal:  Rev Esp Quimioter       Date:  2001-06       Impact factor: 1.553

8.  Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori.

Authors:  Jacques Tankovic; Christine Lascols; Quentin Sculo; Jean-Claude Petit; Claude-James Soussy
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

9.  Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.

Authors:  Marco Romano; Riccardo Marmo; Antonio Cuomo; Teresa De Simone; Caterina Mucherino; Maria Rosaria Iovene; Fortunato Montella; Maria Antonietta Tufano; Camillo Del Vecchio Blanco; Gerardo Nardone
Journal:  Clin Gastroenterol Hepatol       Date:  2003-07       Impact factor: 11.382

10.  Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments.

Authors:  M Neri; A Milano; F Laterza; G Di Bonaventura; R Piccolomini; M P Caldarella; C Balatsinou; D Lapenna; F Cuccurullo
Journal:  Aliment Pharmacol Ther       Date:  2003-10-15       Impact factor: 8.171
View more
  23 in total

1.  Antibiotics resistance rate of Helicobacter pylori in Bhutan.

Authors:  Ratha-korn Vilaichone; Yoshio Yamaoka; Seiji Shiota; Thawee Ratanachu-ek; Lotay Tshering; Tomohisa Uchida; Toshio Fujioka; Varocha Mahachai
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

2.  Second-line rescue therapy of helicobacter pylori infection.

Authors:  Javier P Gisbert
Journal:  Therap Adv Gastroenterol       Date:  2009-11       Impact factor: 4.409

Review 3.  "Rescue" regimens after Helicobacter pylori treatment failure.

Authors:  Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 4.  Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.

Authors:  Sinéad M Smith; Colm O'Morain; Deirdre McNamara
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

5.  Helicobacter pylori resistance rates for levofloxacin, tetracycline and rifabutin among Irish isolates at a reference centre.

Authors:  A O'Connor; I Taneike; A Nami; N Fitzgerald; B Ryan; N Breslin; H O'Connor; D McNamara; P Murphy; C O'Morain
Journal:  Ir J Med Sci       Date:  2013-04-27       Impact factor: 1.568

6.  In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.

Authors:  J-C Yang; P-I Lee; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-25       Impact factor: 3.267

7.  The incidence of primary antibiotic resistance of Helicobacter pylori in Vietnam.

Authors:  Tran T Binh; Seiji Shiota; Lam T Nguyen; Dung D Q Ho; Hai H Hoang; Long Ta; Dung T Trinh; Toshio Fujioka; Yoshio Yamaoka
Journal:  J Clin Gastroenterol       Date:  2013-03       Impact factor: 3.062

8.  Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy.

Authors:  Jingxian Liao; Qing Zheng; Xiao Liang; Wei Zhang; Qinjuan Sun; Wenzhong Liu; Shudong Xiao; David Y Graham; Hong Lu
Journal:  Helicobacter       Date:  2013-04-15       Impact factor: 5.753

9.  Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial.

Authors:  Josip Bago; Karolina Majstorović; Zeljka Belosić-Halle; Nastja Kućisec; Vinko Bakula; Monika Tomić; Petra Bago; Rosana Troskot
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-04-15       Impact factor: 3.944

10.  Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori.

Authors:  Emmanuelle Cambau; Vera Allerheiligen; Céline Coulon; Céline Corbel; Christine Lascols; Lionel Deforges; Claude-James Soussy; Jean-Charles Delchier; Francis Megraud
Journal:  J Clin Microbiol       Date:  2009-09-16       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.